MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21037/tau.2020.01.05

Медицинская библиотека · Translational andrology and urology · 2020

A safety and efficacy analysis of direct-antiviral therapy in patients with chronic hepatitis C after renal transplantation.

Li Guanghui, Ma Junjie, Xu Lu, Fang Jiali, Zhang Lei, Wu Jialin, Lai Xingqiang, Liu Luhao, Xiong Yunyi, Yin Wei, Zhang Tao, Zhang Peng, Li Li, Chen Rongxin, Wang Jiao, Chen Zheng

СтатьяПеревод в очереди

Аннотация

BACKGROUND

To explore the safety and efficacy of direct antiviral therapy in patients with hepatitis C virus (HCV) infection after renal transplantation.

METHODS

We retrospectively reviewed the medical information of 15 cases of HCV+ patients treated with direct antiviral therapy after renal transplantation in our center. The effectiveness of direct antiviral therapy was evaluated by analyzing the HCV-RNA levels of patients at 1, 4, 12, 24, and 48 weeks before and after antiviral therapy. In addition, parameters including the rejection rate, the blood concentration of anti-rejection drugs, liver function level [alanine aminotransferase (ALT), aspartate transaminase (AST)], estimated glomerular filtration rate (eGFR) and serum creatinine (CREA) levels were used to assess its safety.

RESULTS

A total of 15 patients were enrolled in the study. All patients turned HCV-RNA negative after 12 weeks of direct-antiviral therapy; the serological test of all patients demonstrated an 100% response rate in rapid virological response (RVR) (15/15), 12-week sustained virological response (SVR12), and 24-week sustained virological response (SVR24). In addition, compared to pre-treatment, the liver function within 12, 24, and 48 weeks after treatment was significantly improved. Moreover, eGFR, CREA, and anti-rejection drug concentration remained stable while acute rejection reaction and other obvious side effects were not observed throughout the treatment period.

CONCLUSIONS

The direct antiviral therapy was well-tolerated and effective for patients with chronic hepatitis C after renal transplantation.

Для цитирования: Li Guanghui, Ma Junjie, Xu Lu, Fang Jiali, Zhang Lei, Wu Jialin, Lai Xingqiang, Liu Luhao, Xiong Yunyi, Yin Wei, Zhang Tao, Zhang Peng, Li Li, Chen Rongxin, Wang Jiao, Chen Zheng. A safety and efficacy analysis of direct-antiviral therapy in patients with chronic hepatitis C after renal transplantation.. Translational andrology and urology. 2020. DOI: 10.21037/tau.2020.01.05.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.